IP Library › Assignment 033588/0427
Patent Assignment
Reel/Frame 033588/0427

Assignment of Assignor's Interest

Recorded: 2014-08-22 Pages: 9
Assignor
SIGA TECHNOLOGIES INC.
Executed: 2014-08-18
Assignee
KINETA FOUR LLC
219 TERRY AVENUE NORTH, SUITE 300, SEATTLE`, WASHINGTON, 98109
Covered Properties (24)
Sulfonyl Semicarbazides, Carbonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 7,994,221 →
Application: 11/653,972 →
Publication: US 2010/0256096
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 7,872,037 →
Application: 11/712,918 →
Publication: US 2007/0254934
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Patent: 8,642,596 →
Application: 11/791,926 →
Publication: US 2009/0203675
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 7,977,365 →
Application: 12/111,778 →
Publication: US 2008/0300265
Anti-Arenaviral Compounds
Patent: 8,106,058 →
Application: 12/162,395 →
Publication: US 2009/0180980
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,148,428 →
Application: 12/281,081 →
Publication: US 2009/0036513
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,461,177 →
Application: 12/673,983 →
Publication: US 2011/0064693
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,623,347 →
Application: 12/735,392 →
Publication: US 2011/0027227
Anti-Viral Drugs for Treatment of Arenavirus Infection
Patent: 8,629,170 →
Application: 12/912,325 →
Publication: US 2011/0172281
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 8,410,149 →
Application: 12/914,400 →
Publication: US 2012/0022027
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Patent: 8,658,697 →
Application: 12/925,702 →
Publication: US 2011/0118505
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Patent: 8,664,274 →
Application: 13/176,866 →
Publication: US 2013/0261087
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,871,746 →
Application: 13/293,849 →
Publication: US 2012/0071447
Anti-Arenaviral Compounds
Patent: 8,518,951 →
Application: 13/338,726 →
Publication: US 2012/0107276
Anti-Arenaviral Compounds
Patent: 8,791,110 →
Application: 13/339,478 →
Publication: US 2012/0308519
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 9,199,920 →
Application: 13/402,125 →
Publication: US 2012/0149751
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,492,434 →
Application: 13/402,167 →
Publication: US 2013/0165493
Sulfonyl Semicarbazides, Semicarbazides and Ureas,Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 9,115,065 →
Application: 13/777,630 →
Publication: US 2014/0378681
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,754,082 →
Application: 13/890,825 →
Publication: US 2014/0128426
Antiviral Drugs for Treatment of Arenavirus Infection
Application: 14/091,723 →
Publication: US 2014/0100245
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 9,067,873 →
Application: 14/134,165 →
Publication: US 2014/0275037
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 9,096,597 →
Application: 14/272,060 →
Publication: US 2014/0243367
Anti-Arenaviral Compounds
Application: 14/314,249 →
Publication: US 2014/0301979
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 9,498,470 →
Application: 14/379,028 →
Publication: US 2015/0023916
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License Jul 16, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028557/0498 →
Confirmatory License Jul 16, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028557/0522 →
Confirmatory License Jul 17, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028571/0641 →
Assignment of Assignor's Interest Aug 21, 2012
From: AMBERG, SEAN M.; DAI, DONGCHENG; BOLKEN, TOVE' C.; HRUBY, DENNIS E.
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 028821/0404 →
Confirmatory License Oct 18, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029151/0189 →
Security Agreement Dec 31, 2012
From: SIGA TECHNOLOGIES, INC.
To: GE CAPITAL EQUITY INVESTMENTS, INC. C/O GE HEALTHCARE FINANCIAL SERVICES, INC.
Reel/Frame 029557/0771 →
Assignment of Assignor's Interest Jun 25, 2014
From: AMBERG, SEAN M.; DAI, DONGCHENG; BOLKEN, TOVE C.; HRUBY, DENNIS E.
To: SIGA TECHNOLOGIES, INC.,
Reel/Frame 033174/0551 →
Release of Security Interest Aug 14, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: SIGA TECHNOLOGIES INC.
Reel/Frame 033544/0324 →
Release of Security Interest Apr 2, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 035319/0001 →
Confirmatory License Apr 8, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052344/0786 →
Confirmatory License May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0611 →
Confirmatory License May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0609 →
Confirmatory License Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0656 →
Confirmatory License Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0736 →